InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Chardonnet Laurent, Chief Financial Officer. Officer active across 1 company, notably Prelude Therapeutics Inc. Cumulatively, 4 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €40k. History available since 13 December 2021. The latest transaction was filed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
10,000 shares@ US$4.230.011% mcap20.6% of flowCommon StockSEC:0001562180-22-004627:0
Ideal exit: 26 Feb 2023 (T+270)
6,500 shares@ US$7.510.012% mcap23.0% of flowCommon StockSEC:0001209191-22-020585:0
5,000 shares@ US$12.280.015% mcap100.0% of flowCommon StockSEC:0001209191-21-069548
5,000 shares@ US$12.280.015% mcap28.2% of flowCommon StockSEC:0001209191-21-069548:0
4 of 4 declarations
About Chardonnet Laurent
Laurent Chardonnet is the Chief Financial Officer at Prelude Therapeutics Inc. He is responsible for financial management and strategy of the company. His role is crucial in ensuring financial health and growth.
